HRC-201

N/A

Report date: 2024/12/02 11:06:03

Base Information

Drug NameHRC-201
Drug Alias NameN/A
ClassificationBiologics > Protein drugsRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionMagnetic resonance imaging enhancersRadionuclide imaging enhancersHemoglobins modulators
TargetsHemoglobins
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHemosol Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherapure Biopharma Inc
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A